Treatment and Prognostic Factors in Primary Peritoneal Carcinoma: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)

Publisher： Karger

E-ISSN： 2296-5262|37|6|332-338

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.6, 2014-05, pp. : 332-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

By  

Oncology Research and Treatment, Vol. 35, Iss. 12, 2012-10 ,pp. : 740-745

Karger

Access to resources Recommend Favorite

Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

By  

Oncology, Vol. 83, Iss. 3, 2012-07 ,pp. : 141-150

Karger

Access to resources Recommend Favorite

Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society

By  

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 412-415

Karger

Access to resources Recommend Favorite

Prognostic Factors for Carcinoma of the Prostate

By  

Urologia Internationalis, Vol. 63, Iss. 1, 1999-12 ,pp. : 62-71

Karger

Access to resources Recommend Favorite

Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E448-E453

John Wiley & Sons Inc

Access to resources Recommend Favorite